Reports Q3 revenue $4.9B, consensus $4.87B. GE HealthCare (GEHC) President and CEO Peter Arduini said, “In the third quarter, we reported sales and orders growth of 1% globally. Both sales and orders grew in the mid-single digits excluding China, with particular strength in the U.S. across all segments. Pharmaceutical Diagnostics also delivered solid performance, driven by healthy procedure volumes. Ongoing lean initiatives across the organization are delivering better value to patients and customers and have resulted in robust margin expansion.”
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GEHC:
- Notable companies reporting before tomorrow’s open
- GE HealthCare announces CareIntellect for Oncology application
- General Electric (NYSE:GE) Earnings Preview: Here’s What to Expect
- GE HealthCare says major academic medical center adopts Hospital Pulse Tile
- GE HealthCare completes manganese-based MRI clinical development program